Affiliation:
1. University Children's Hospital, Tübingen, Federal Republic of Germany.
Abstract
Of six new oral cephalosporins, cefixime and cefpodoxime were the most active (MIC for 90% of isolates tested [MIC90], 16 micrograms/ml) against Bordetella pertussis, followed by cefetamet, cefprozil, and loracarbef (LY163892) (MIC90, 64 micrograms/ml) and ceftibuten (MIC90, 128 micrograms/ml). Against Bordetella parapertussis, loracarbef was more active (MIC90, 32 micrograms/ml) than the other compounds tested (MIC90s, 64 to greater than 128 micrograms/ml). The new oral cephalosporins are unlikely to play a role in pertussis treatment.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference9 articles.
1. Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem;Bannatyne R. M.;Antimicrob. Agents Chemother.,1984
2. Deutsches Institut fur Normung. 1979. Methods for the determination of susceptibility of pathogenic bacteria (without mycobacteria) to chemotherapeutic agents; determination of MIC by agar dilution method. DIN 58940 part 6. Deutsches Institut fur Normung Berlin.
3. Serum and sputum concentration and clinical results of cefixime in respiratory tract infections;Hayashi I.;Chemotherapy (Tokyo),1985
4. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis;Hoppe J. E.;Eur. J. Clin. Microbiol. Infect. Dis.,1989
5. Susceptibility of Bordetella pertussis and Bordetella parapertussis to twenty-four antibiotics;Hoppe J. E.;Chemotherapy (Basel),1987
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献